150 related articles for article (PubMed ID: 49112)
21. Localization of T and B cells and alpha fetoprotein in hepatic biopsies from patients with liver disease.
Husby G; Strickland RG; Caldwell JL; Williams RC
J Clin Invest; 1975 Nov; 56(5):1198-1209. PubMed ID: 52655
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus serological markers in Africans with liver cirrhosis and hepatocellular carcinoma.
Coursaget P; Chiron JP; Barres JL; Barin F; Cottey P; Tortey E; Yvonnet B; Diop B; MBoup S; Diop-Mar I
IARC Sci Publ; 1984; (63):181-98. PubMed ID: 6085625
[TBL] [Abstract][Full Text] [Related]
23. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
24. Incidence and nature of cytoplasmic hepatitis B antigen in hepatocytes.
Gerber MA; Hadziyannis S; Vernace S; Vissoulis C
Lab Invest; 1975 Feb; 32(2):251-6. PubMed ID: 46330
[TBL] [Abstract][Full Text] [Related]
25. [Incidence of HBAg in various liver diseases (comparison between radioimmunologic methods and methods of passive hemagglutination)].
Claar GM; Alvaro MC; Ascione A; De Bellis G; Sodano S; Varone GL
Quad Sclavo Diagn; 1975 Jun; 11(2):561-6. PubMed ID: 1223959
[TBL] [Abstract][Full Text] [Related]
26. The detection of alpha 1-fetoprotein in patients with viral hepatitis.
Silver HK; Deneault J; Gold P; Thompson WG; Shuster J; Freedman SO
Cancer Res; 1974 Jan; 34(1):244-7. PubMed ID: 4809461
[TBL] [Abstract][Full Text] [Related]
27. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
Gessoni G; Manoni F
Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological features of hepatocellular carcinomas (HCCs) arising in patients without chronic viral infection or alcohol abuse: a retrospective study of patients undergoing hepatic resection.
Yokoi Y; Suzuki S; Baba S; Inaba K; Konno H; Nakamura S
J Gastroenterol; 2005 Mar; 40(3):274-82. PubMed ID: 15830287
[TBL] [Abstract][Full Text] [Related]
29. [Frequency of antigen associated to hepatitis due to virus B (HBAg) and of antibody (HBAc) in healthy subjects and during of course of acute and chronic hepatitis. Radioimmunologic study].
Realdi G; Tremolada F; Alberti A; Rigoli A; Diodati G; Visconti M
Quad Sclavo Diagn; 1975 Jun; 11(2):419-30. PubMed ID: 1223946
[TBL] [Abstract][Full Text] [Related]
30. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
Dávid K; Halmy L
Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
[TBL] [Abstract][Full Text] [Related]
31. Alpha-fetoprotein (AFP) in benign liver disease. Evidence that normal liver regeneration does not induce AFP synthesis.
Alpert E; Feller ER
Gastroenterology; 1978 May; 74(5 Pt 1):856-8. PubMed ID: 76587
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens.
Omata M; Ashcavai M; Liew CT; Peters RL
Gastroenterology; 1979 Feb; 76(2):279-87. PubMed ID: 215488
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.
Mwangi J; Gatei DG
East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308
[TBL] [Abstract][Full Text] [Related]
34. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
Han Y; Tang Q; Zhu W; Zhang X; You L
J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
[TBL] [Abstract][Full Text] [Related]
35. Correlation between plasma levels of matrix metalloproteinase (MMP)-9 /MMP-2 ratio and alpha-fetoproteins in chronic hepatitis carrying hepatitis B virus.
Chung TW; Kim JR; Suh JI; Lee YC; Chang YC; Chung TH; Kim CH
J Gastroenterol Hepatol; 2004 May; 19(5):565-71. PubMed ID: 15086601
[TBL] [Abstract][Full Text] [Related]
36. [Occurrence of increased alpha-fetoprotein in non-neoplastic hepatopathies of alcoholic or non-alcoholic origin].
Pol S; Nalpas B; Bezeaud A; Bréchot C; Berthelot P
Gastroenterol Clin Biol; 1986 Feb; 10(2):112-6. PubMed ID: 2422087
[TBL] [Abstract][Full Text] [Related]
37. Current views on liver diseases in Ethiopia.
Tsega E
Ethiop Med J; 1977 Apr; 15(2):75-82. PubMed ID: 201462
[TBL] [Abstract][Full Text] [Related]
38. [Alpha 1 fetoprotein-determiantion in patients with liver diseases].
Lamerz R; Schmalhorst U; Grunst J
Z Gastroenterol Verh; 1976; (11):49-53. PubMed ID: 65863
[No Abstract] [Full Text] [Related]
39. [Geographical differences in the incidence of Australia antigen in chronic liver diseases].
Del Vecchio Blanco C; Rinaldi M; Saffiotti O; Caporaso N; Coltorti M
Quad Sclavo Diagn; 1975 Jun; 11(2):500-7. PubMed ID: 1223953
[TBL] [Abstract][Full Text] [Related]
40. [Australia antigen and chronic hepatic diseases in the western African].
Payet M; Saimot G; Menache D; Chemaly P; Coulaud JP; Schlegel N
Ann Med Interne (Paris); 1972 Feb; 123(2):175-9. PubMed ID: 4341131
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
